Evidence map›Paper›PMID 30696098›Full record

ReviewCells2019

Implications and Current Limitations of Oogenesis from Female Germline or Oogonial Stem Cells in Adult Mammalian Ovaries.

Jessica J Martin, Dori C Woods, Jonathan L Tilly

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Cells, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05279560 (The Efficacy and Safety of Intra-ovarian PRP Injection Within a Prospective, Single-blinded, Placebo-controlled, Randomized, Clinical Superiority Trial in Subjects With Low Ovarian Reserve/Expected Poor Ovarian Response), which is not on this map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
12.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05279560 naactive not recruitingnot on this mapstarted 2022, after this paper: background citation

The Efficacy and Safety of Intra-ovarian PRP Injection Within a Prospective, Single-blinded, Placebo-controlled, Randomized, Clinical Superiority Trial in Subjects With Low Ovarian Reserve/Expected Poor Ovarian Response

TypeinterventionalSponsorUniversity of LuebeckRan2022 to 2030Enrolled114ConditionsPremature Ovarian Insufficiency, Infertility, Female, Sterility, Female, PRPArmsautologous PRP (platelet rich plasma), Saline solution (NaCL) Injection
3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 85 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Advances inFrontiers in endocrinology · 2025
    Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. iScience · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jessica J MartinLaboratory of Aging and Infertility Research, Department of Biology, Northeastern University, Boston, MA 02115, USA. martin.je@husky.neu.edu.
Dori C WoodsLaboratory of Aging and Infertility Research, Department of Biology, Northeastern University, Boston, MA 02115, USA. d.woods@northeastern.edu.
Jonathan L TillyLaboratory of Aging and Infertility Research, Department of Biology, Northeastern University, Boston, MA 02115, USA. j.tilly@northeastern.edu.
Northeastern University · US

Funding

Origins and Functions of Mammalian Female Germline Stem CellsR01AG012279 · NIA · NORTHEASTERN UNIVERSITY · PI TILLY, JONATHAN LEE · 1995 to 2021
$2.7M
Lineage tracing of germline stem cell differentiation in adult ovariesR21HD072280 · NICHD · NORTHEASTERN UNIVERSITY · PI TILLY, JONATHAN LEE, WANG, NING · 2012 to 2013
$422k
NIA NIH HHS R01 AG012279NICHD NIH HHS R21 HD072280
6 · The paper itself

Abstract

A now large body of evidence supports the existence of mitotically active germ cells in postnatal ovaries of diverse mammalian species, including humans. This opens the possibility that adult stem cells naturally committed to a germline fate could be leveraged for the production of female gametes outside of the body. The functional properties of these cells, referred to as female germline or oogonial stem cells (OSCs), in ovaries of women have recently been tested in various ways, including a very recent investigation of the differentiation capacity of human OSCs at a single cell level. The exciting insights gained from these experiments, coupled with other data derived from intraovarian transplantation and genetic tracing analyses in animal models that have established the capacity of OSCs to generate healthy eggs, embryos and offspring, should drive constructive discussions in this relatively new field to further exploring the value of these cells to the study, and potential management, of human female fertility. Here, we provide a brief history of the discovery and characterization of OSCs in mammals, as well as of the in-vivo significance of postnatal oogenesis to adult ovarian function. We then highlight several key observations made recently on the biology of OSCs, and integrate this information into a broader discussion of the potential value and limitations of these adult stem cells to achieving a greater understanding of human female gametogenesis in vivo and in vitro.

Indexed as

OogenesisAnimalsFemaleGerm CellsHumansMammalsOogonial Stem CellsOvaryReproductive Techniques, Assistedfertilitygerm cellgermline stem cellmeiosisoocyteoogenesisoogonial stem cellovary

Identifiers

PMID30696098
PMCPMC6407002
OpenAlexW2914336299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.